biorestorative
-
Biologics
BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
MELVILLE, N.Y., June 28, 2016 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BRT” or the “Company”) (OTCBB:BRTX), a life sciences company…
Read More » -
BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure
JUPITER, Fla., Jan. 31, 2012 /PRNewswire/ — BioRestorative Therapies, Inc. (OTCQB: BRTX) (“BRT”) today announced that it has entered into a License Agreement…
Read More »